Geron Corporation —— 现金流量表 (NASDAQ:GERN)

Financials

经营活动产生的现金 -66.65 M-95.56 M-127.38 M-167.74 M-218.62 M-111.04 M -111.04 M 投资活动产生的现金 -105.32 M71.95 M62.07 M-180.32 M-106 M107.25 M 107.25 M 融资活动产生的现金 168.35 M48.56 M87.26 M362.02 M334.37 M2.27 M 2.27 M 自由现金流 -67.05 M-95.76 M-127.81 M-168.57 M-219.3 M-111.04 M -111.04 M

Geron Corporation

Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.

GERN

Financials

Geron Corporation

新闻

杰龙在Barclays医疗保健会议上展示战略增长与未来规划

Geron at Barclays Healthcare Conference: Strategic Growth and Future Plans

Geron Corporation (GERN) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Can Reblozyl Stabilize BMY's Top Line Amid Legacy Drugs Decline?

杰龙在TD Cowen会议上:战略增长与市场扩张

Geron at TD Cowen: Strategic Growth and Market Expansion

Geron: Why I'm Doubling Down On My 'Sell' Rating After Q4 Earnings (NASDAQ:GERN)

Geron Corporation (GERN) Q4 2025 Earnings Call Transcript

Geron (GERN) Reports Q4 Loss, Misses Revenue Estimates

杰龙Q4每股收益及营收逊于预期

Geron earnings missed by $0.02, revenue fell short of estimates

杰龙财报即将公布:RYTELO能否保持营收增长势头?